{"name":"Rong Hu, MD","slug":"rong-hu-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Cattle Encephalon Glycoside and Ignotin","genericName":"Cattle Encephalon Glycoside and Ignotin","slug":"cattle-encephalon-glycoside-and-ignotin","indication":"Cerebrovascular disease","status":"phase_3"}]}],"pipeline":[{"name":"Cattle Encephalon Glycoside and Ignotin","genericName":"Cattle Encephalon Glycoside and Ignotin","slug":"cattle-encephalon-glycoside-and-ignotin","phase":"phase_3","mechanism":"Cattle encephalon glycoside and ignotin is a neuroprotective agent derived from bovine brain tissue that enhances neuronal metabolism and cerebral blood flow.","indications":["Cerebrovascular disease","Ischemic stroke recovery","Neurodegenerative conditions"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNOExkQXBQbTdxd0tDVm1oNTUwNGhfbU9NVDFlU3FPckZxVk4wUElkSF84OHJFNHg1bHdNMjFBYzdjOUdUczFYUENRd2xuSkU5T0w0ZEtqbE9DXzRLT1pkQ1QxU3VqbmhNSC1MNERMVWxObTctMGtaNGN3TWNIY0J6TWIxQ3k5cjNodG9qbV9qZGc?oc=5","date":"2022-06-29","type":"pipeline","source":"American Heart Association Journals","summary":"Colchicine Ameliorates Dilated Cardiomyopathy Via SIRT2 ‐Mediated Suppression of NLRP3 Inflammasome Activation - American Heart Association Journals","headline":"Colchicine Ameliorates Dilated Cardiomyopathy Via SIRT2 ‐Mediated Suppression of NLRP3 Inflammasome Activation","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}